De Novo Mutation in Genes Regulating Neural Stem Cell Fate in Human Congenital Hydrocephalus

Area of Science:

• Genetics
• Neuroscience
• Developmental Biology

Background:

• Congenital hydrocephalus (CH) is characterized by enlarged brain ventricles, often attributed to cerebrospinal fluid (CSF) imbalance.
• Current treatments involve lifelong CSF shunting, associated with significant morbidity.
• The underlying pathogenesis of CH remains poorly understood.

Purpose of the Study:

• To investigate the genetic basis of congenital hydrocephalus.
• To identify genes and pathways involved in CH pathogenesis.
• To explore novel diagnostic and therapeutic targets for CH.

Main Methods:

• Exome sequencing was performed on 125 congenital hydrocephalus trios and 52 additional probands.
• Statistical analysis was used to identify genes with a significant burden of rare damaging de novo or transmitted mutations.
• Analysis included identification of de novo duplications at the SHH locus.

Main Results:

• Significant mutations in TRIM71, SMARCC1, and PTCH1 were identified in CH patients.
• De novo duplications at the SHH locus were also found.
• These genes are crucial for neural tube development and neural stem cell fate, accounting for approximately 10% of studied cases.

Conclusions:

• Impaired neurogenesis, rather than active CSF accumulation, is implicated in the pathogenesis of a subset of CH patients.
• These findings suggest potential new diagnostic and therapeutic strategies for CH.
• The identified genes offer insights into the developmental origins of CH.